// App-Quantinova.ai

1604 : IMI CANCER-ID: Validation of novel blood-based biomarker technologies in clinical settings

Researchers

Presenter

  • Thomas Schlange

Principal Investigators

  • Thomas Krahn

  • Sabrina Pleier

  • Klaus Pantel

  • Leon WMM Terstappen

  • Barbara Baggiani

Medical Centers

  • Menarini Silicon Biosystems, Inc., Bologna, Italy

  • Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany

  • Universiteit Twente, Twente, Netherlands

Locations

  • Germany

  • Italy

  • Netherlands

Companies

  • Bayer

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Breast cancer

  • Small cell lung cancer

  • Lung Cancer

Biomarkers

  • Circulating tumor cells

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved